Literature DB >> 17498268

Allograft inflammatory factor-1 and tumor necrosis factor single nucleotide polymorphisms in systemic sclerosis.

F G Otieno1, A M Lopez, S A Jimenez, J Gentiletti, C M Artlett.   

Abstract

Tumor necrosis factor (TNF) alleles have been associated with systemic sclerosis (SSc); however, these alleles may be in linkage with other genes. Allograft inflammatory factor-1 (AIF-1) is a newly identified gene on the short arm of chromosome 6 in the class III region of the human leukocyte antigen. It appears to be involved in inflammation and was originally identified in rat cardiac allografts undergoing rejection. AIF-1 has several sequence variations (single nucleotide polymorphisms, SNPs), three of which result in nonsynonymous changes in amino acid coding. We analyzed the linkage of five TNFA and five AIF-1 SNPs by polymerase chain reaction in 239 Caucasian individuals. The TNFA-1031T/T genotype was found to be associated with SSc (P < 0.0001) and both the DcSSc (diffuse subset of SSc) and the LcSSc (limited subset of SSc) subsets (P= 0.0004 and P= 0.0009, respectively) and the TNFA-237G/G genotype was found to be associated with all SSc (P= 0.0003) and with the DcSSc and LcSSc subsets (P= 0.01 and P= 0.005, respectively). Furthermore, the TNFA-857C/T genotype was associated with LcSSc (P= 0.0003) and TNFA-307A/A genotype associated with DcSSc (P= 0.028). In AIF-1, RS2269475 exon 4A allele, which generates a nonsynonymous change (tryptophan to arginine), was significantly associated in patients with SSc (P= 0.0009) and was associated with those patients who had DcSSc (P= 0.002). A strong linkage disequilibrium was observed between the AIF-1 alleles, A allele of RS2269475 and the A allele of RS4711274 (P < 0.0001), and linkage was observed between AIF-1 and TNFA alleles. Here, we report a novel and significant association of a nonsynonymous change within the AIF-1 with SSc and identified the linkage with TNFA alleles within 50 kb of this gene. Our study lends support that TNFA may be an important inflammatory modulator in SSc and may play a significant role with AIF-1 in disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17498268     DOI: 10.1111/j.1399-0039.2007.00830.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

1.  Allograft inflammatory factor-1 in myeloid cells drives autoimmunity in type 1 diabetes.

Authors:  Diana M Elizondo; Nailah Zd Brandy; Ricardo L da Silva; Tatiana R de Moura; Michael W Lipscomb
Journal:  JCI Insight       Date:  2020-05-21

2.  Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling".

Authors:  Stephanos Pavlides; Aristotelis Tsirigos; Iset Vera; Neal Flomenberg; Philippe G Frank; Mathew C Casimiro; Chenguang Wang; Richard G Pestell; Ubaldo E Martinez-Outschoorn; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Aging (Albany NY)       Date:  2010-04       Impact factor: 5.682

3.  AIF-1 expression regulates endothelial cell activation, signal transduction, and vasculogenesis.

Authors:  Ying Tian; Surbhi Jain; Sheri E Kelemen; Michael V Autieri
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-11       Impact factor: 4.249

Review 4.  Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis.

Authors:  Gabriela Kania; Michal Rudnik; Oliver Distler
Journal:  Nat Rev Rheumatol       Date:  2019-05       Impact factor: 20.543

5.  Genetic Susceptibility to Systemic Sclerosis in the Greek-Cypriot Population: A Pilot Study.

Authors:  Paraskevi Chairta; Savvas Psarelis; Kyriaki Michailidou; Christiana Demetriou; Sofia Symeonidou; Paschalis Nicolaou; Kyproula Christodoulou
Journal:  Genet Test Mol Biomarkers       Date:  2020-04-21

6.  Over-Expression of Allograft Inflammatory Factor-1 (AIF-1) in Patients with Rheumatoid Arthritis.

Authors:  Katarzyna Piotrowska; Sylwia Słuczanowska-Głabowska; Mateusz Kurzawski; Violetta Dziedziejko; Patrycja Kopytko; Edyta Paczkowska; Dorota Rogińska; Krzysztof Safranow; Bogusław Machaliński; Andrzej Pawlik
Journal:  Biomolecules       Date:  2020-07-16

Review 7.  Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification.

Authors:  Changyi Yang; Shunli Tang; Dingxian Zhu; Yingguo Ding; Jianjun Qiao
Journal:  Front Med (Lausanne)       Date:  2020-11-19

8.  Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus.

Authors:  Doua F Azzouz; Gabriel V Martin; Fanny Arnoux; Nathalie Balandraud; Thierry Martin; Sylvain Dubucquoi; Eric Hachulla; Dominique Farge-Bancel; Kiet Tiev; Jean Cabane; Nathalie Bardin; Laurent Chiche; Marielle Martin; Eléonore C Caillet; Sami B Kanaan; Jean Robert Harlé; Brigitte Granel; Elisabeth Diot; Jean Roudier; Isabelle Auger; Nathalie C Lambert
Journal:  PLoS One       Date:  2016-09-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.